1. copies of previously prescription products
2. expired or almost expired
3. usually without proprietary names (non-proprietary)
without therapeutic misadventure
4. EGMA: essentially similar
a. having the same qualitative and quantitative composition in terms of active principles
b. having the same pharmaceutical form
c. being bioequivalent
ECJ:
1. Chemical name
2. Generic (non-proprietary) name
3. Brand (proprietary) name: promotion
Eg. Lisinopril (Merck) -> Carace (DuPont) or Zestril (Zeneca)
Innovator products : usually one source (patent protection)
Proprietary
-Branded generic (multisource)
-Unbranded generic
沒有留言:
張貼留言